Background Blood OX40-expressing CD4 T-cells from antiretroviral (ART)-treated people living with HIV (PWH) were found to be enriched for clonally-expanded HIV sequences, hence contributing to the HIV reservoir. OX40-OX40L is also a checkpoint regulator of inflammation in multiple diseases. We explored gut mucosal OX40+CD4+ T-cells and their...
-
February 26, 2024 (v1)PublicationUploaded on: February 28, 2024
-
September 30, 2024 (v1)Publication
BACKGROUNDWe evaluated the safety and viral rebound, after analytical treatment interruption (ATI), of vedolizumab and ART in recent HIV-1 infection. We used this model to analyze the effect of α4β7 on the HIV-1 reservoir size.METHODSParticipants started ART with monthly vedolizumab infusions, and ATI was performed at week 24. Biopsies were...
Uploaded on: October 1, 2024 -
November 4, 2022 (v1)Publication
Instituto de Salud Carlos III CM19/00051, CD19/00143, FI19/00298
Uploaded on: March 24, 2023